TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Amiodarone on the Procedure Outcome in Long-standing Persistent Atrial Fibrillation Undergoing Pulmonary Vein Antral Isolation
Brief Summary: This prospective randomized study aims to investigate the effect of continuous versus interrupted use of Amiodarone on the procedure outcome in long-standing persistent (LSP) atrial fibrillation patients undergoing pulmonary vein antral isolation (PVAI).


Options:
A: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amiodarone | Arm Label: Study; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amiodarone | Intervention Type: DRUG; Name: Amiodarone; Assigned to Arm(s): Control | Intervention Type: DRUG; Name: Amiodarone; Assigned to Arm(s): Study
B: Arm Label: Dormant PV conduction; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Additional ablation until elimination of dormant conduction, Procedure: No additional ablation | Arm Label: No dormant PV conduction; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Registry group, Procedure: Usual medical care | Intervention Type: PROCEDURE; Name: Additional ablation until elimination of dormant conduction; Assigned to Arm(s): Dormant PV conduction | Intervention Type: PROCEDURE; Name: No additional ablation; Assigned to Arm(s): Dormant PV conduction | Intervention Type: PROCEDURE; Name: Registry group; Assigned to Arm(s): No dormant PV conduction | Intervention Type: PROCEDURE; Name: Usual medical care; Assigned to Arm(s): No dormant PV conduction
C: Arm Label: Drug Treatment; Type: ACTIVE_COMPARATOR; Interventions: Device: Radiofrequency ablation, antiarrhythmic drugs, Drug: Amiodarone, flecainide, propafenone, quinidine, dofetilide, sotalol, cibenzoline, beta blocking and calcium channel blocking agents and antiarrhythmic drugs | Arm Label: ThermoCool Radiofrequency Catheter; Type: ACTIVE_COMPARATOR; Interventions: Device: Radiofrequency ablation, antiarrhythmic drugs, Device: ThermoCool Radiofrequency Catheter | Intervention Type: DEVICE; Name: Radiofrequency ablation, antiarrhythmic drugs; Assigned to Arm(s): Drug Treatment, ThermoCool Radiofrequency Catheter | Intervention Type: DRUG; Name: Amiodarone, flecainide, propafenone, quinidine, dofetilide, sotalol, cibenzoline, beta blocking and calcium channel blocking agents and antiarrhythmic drugs; Assigned to Arm(s): Drug Treatment | Intervention Type: DEVICE; Name: ThermoCool Radiofrequency Catheter; Assigned to Arm(s): ThermoCool Radiofrequency Catheter
D: Arm Label: Left Atrial Ablation; Type: ACTIVE_COMPARATOR; Interventions: Device: Left atrial ablation | Arm Label: Rate or Rhythm Control Therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Rate or Rhythm Control Therapy | Intervention Type: DEVICE; Name: Left atrial ablation; Assigned to Arm(s): Left Atrial Ablation | Intervention Type: DRUG; Name: Rate or Rhythm Control Therapy; Assigned to Arm(s): Rate or Rhythm Control Therapy

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Processed Residual Pump Blood in Cardiac Surgery: The PRBC Trial
Brief Summary: The study is an randomized controlled trial (RCT) of 198 coronary artery bypass graft (CABG) patients, exploring whether ultrafiltration of residual blood in the cardiopulmonary bypass circuit reduces transfusion and bleeding.


Options:
A: Arm Label: Treatment group; Type: EXPERIMENTAL; Interventions: Other: Ultrafiltration of residual blood | Arm Label: Control; Type: NO_INTERVENTION; Interventions: Other: Ultrafiltration of residual blood | Intervention Type: OTHER; Name: Ultrafiltration of residual blood; Assigned to Arm(s): Control, Treatment group
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Packed Red Blood Cell Transfusion | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Packed Red Blood Cell Transfusion | Intervention Type: PROCEDURE; Name: Packed Red Blood Cell Transfusion; Assigned to Arm(s): 1, 2
C: Arm Label: Low transfusion trigger; Type: ACTIVE_COMPARATOR; Interventions: Biological: red blood cell transfusion | Arm Label: High transfusion trigger; Type: ACTIVE_COMPARATOR; Interventions: Biological: red blood cell transfusion | Intervention Type: BIOLOGICAL; Name: red blood cell transfusion; Assigned to Arm(s): High transfusion trigger, Low transfusion trigger
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: red blood cell transfusion | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: red blood cell transfusion | Intervention Type: PROCEDURE; Name: red blood cell transfusion; Assigned to Arm(s): 1, 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Brief Summary: The investigators hypothesize that cognitive remediation will be superior to the active control group on the change from baseline to study end point of cognitive remediation phase on both co-primary outcome measures (standardized composite MATRICS score and Cognitive Assessment Interview).


Options:
A: Arm Label: Cognitive Remediation; Type: EXPERIMENTAL; Interventions: Drug: Cognitive Remediation | Arm Label: Cognitive activity control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Cognitive Remediation; Assigned to Arm(s): Cognitive Remediation
B: Arm Label: Posit Science Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Targeted cognitive training, Behavioral: Bridging groups | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Computer control, Behavioral: Health and wellness groups | Intervention Type: BEHAVIORAL; Name: Targeted cognitive training; Assigned to Arm(s): Posit Science Intervention | Intervention Type: BEHAVIORAL; Name: Computer control; Assigned to Arm(s): Control | Intervention Type: BEHAVIORAL; Name: Bridging groups; Assigned to Arm(s): Posit Science Intervention | Intervention Type: BEHAVIORAL; Name: Health and wellness groups; Assigned to Arm(s): Control
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Computer games | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Targeted cognitive training (TCT) | Intervention Type: BEHAVIORAL; Name: Targeted cognitive training (TCT); Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: Computer games; Assigned to Arm(s): 1
D: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Computer games | Arm Label: Active; Type: EXPERIMENTAL; Interventions: Behavioral: Neuroadaptive cognitive training | Arm Label: Healthy Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Neuroadaptive cognitive training | Intervention Type: BEHAVIORAL; Name: Neuroadaptive cognitive training; Assigned to Arm(s): Active, Healthy Control | Intervention Type: BEHAVIORAL; Name: Computer games; Assigned to Arm(s): Control

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Delivery, Uptake and Acceptability of HPV Vaccination in Tanzanian Girls
Brief Summary: The aims of this study are:

1. To determine feasibility of a school-based human papillomavirus (HPV) vaccination programme in Tanzania.
2. To measure the uptake and acceptability of two different vaccination strategies in rural and urban schools.
3. To examine the characteristics of accepters/refusers of vaccination and to identify reasons for acceptance, refusal or non-completion.
4. To measure the cost of implementing a school-based HPV vaccination programme in Tanzania.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: AFIX In-Person Visit; Type: EXPERIMENTAL; Interventions: Other: Assessment , Feedback, Incentives, and eXchange Program | Arm Label: AFIX Webinar Visit; Type: EXPERIMENTAL; Interventions: Other: Assessment , Feedback, Incentives, and eXchange Program | Intervention Type: OTHER; Name: Assessment , Feedback, Incentives, and eXchange Program; Assigned to Arm(s): AFIX In-Person Visit, AFIX Webinar Visit
B: Arm Label: Class-based delivery; Type: OTHER; Interventions: Biological: Gardasil® HPV vaccine | Arm Label: Age-based delivery; Type: OTHER; Interventions: Biological: Gardasil® HPV vaccine | Intervention Type: BIOLOGICAL; Name: Gardasil® HPV vaccine; Assigned to Arm(s): Age-based delivery, Class-based delivery
C: Arm Label: Education about HPV by school nurse; Type: EXPERIMENTAL; Interventions: Behavioral: Education about HPV by school nurse | Arm Label: Control group 1; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Education about HPV by school nurse; Assigned to Arm(s): Education about HPV by school nurse
D: Arm Label: Intervention Practices; Type: EXPERIMENTAL; Interventions: Behavioral: Multimodal Vaccine Program | Arm Label: Control Practices; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Multimodal Vaccine Program; Assigned to Arm(s): Intervention Practices

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Assessor-blind, Controlled Trial of Electroacupuncture Combined With Antidepressants in Treating Patients With Post-stroke Depression
Brief Summary: This is a randomized, assessor-blind, placebo controlled study in post stroke depression patients. Subjects receiving antidepressant drug would be assigned to either active or placebo scalp electro-acupuncture treatment, on the hypothesis that acupuncture intervention combined with antidepressants could produce greater therapeutic effects than antidepressants alone.


Options:
A: Intervention Type: PROCEDURE; Name: Acupuncture; Assigned to Arm(s): N/A
B: Arm Label: Conventional treatment; Type: OTHER; Interventions: Behavioral: Conventional treatment | Arm Label: Integrative treatment; Type: EXPERIMENTAL; Interventions: Other: Integrative treatment | Arm Label: Terapeutic acupuncture; Type: ACTIVE_COMPARATOR; Interventions: Other: Therapeutic acupuncture | Intervention Type: BEHAVIORAL; Name: Conventional treatment; Assigned to Arm(s): Conventional treatment | Intervention Type: OTHER; Name: Integrative treatment; Assigned to Arm(s): Integrative treatment | Intervention Type: OTHER; Name: Therapeutic acupuncture; Assigned to Arm(s): Terapeutic acupuncture
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: Electroacupuncture | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Sham | Intervention Type: PROCEDURE; Name: Electroacupuncture; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Sham; Assigned to Arm(s): 2
D: Arm Label: DCEAS; Type: EXPERIMENTAL; Interventions: Procedure: DCEAS (Hwato®/ Dongbang®), Procedure: Body electro-acupuncture (Hwato®/ Dongbang®), Drug: Fluoxetine | Arm Label: n-CEA; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Body electro-acupuncture (Hwato®/ Dongbang®), Procedure: n-CEA (Strietberger®), Drug: Fluoxetine | Intervention Type: PROCEDURE; Name: DCEAS (Hwato®/ Dongbang®); Assigned to Arm(s): DCEAS | Intervention Type: PROCEDURE; Name: Body electro-acupuncture (Hwato®/ Dongbang®); Assigned to Arm(s): DCEAS, n-CEA | Intervention Type: PROCEDURE; Name: n-CEA (Strietberger®); Assigned to Arm(s): n-CEA | Intervention Type: DRUG; Name: Fluoxetine; Assigned to Arm(s): DCEAS, n-CEA

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Drug Eluting Versus Conventional Balloon Angioplasty for the Treatment of Failing Dialysis Access. A Prospective Randomized Single-Center Trial.
Brief Summary: The aim of the study is to compare the feasibility and the effectiveness, by means of immediate and long-term results, of drug eluting balloon (DEB) versus conventional balloon angioplasty for the treatment of failing dialysis access.


Options:
A: Arm Label: FLAIR; Type: EXPERIMENTAL; Interventions: Device: FLAIR Endovascular Stent Graft | Arm Label: PTA Only; Type: ACTIVE_COMPARATOR; Interventions: Procedure: PTA | Arm Label: FLAIR Roll-in Participants; Type: EXPERIMENTAL; Interventions: Device: FLAIR Endovascular Stent Graft | Intervention Type: DEVICE; Name: FLAIR Endovascular Stent Graft; Assigned to Arm(s): FLAIR | Intervention Type: PROCEDURE; Name: PTA; Assigned to Arm(s): PTA Only | Intervention Type: DEVICE; Name: FLAIR Endovascular Stent Graft; Assigned to Arm(s): FLAIR Roll-in Participants
B: Arm Label: Conventional Balloon Angioplasty (COBA); Type: ACTIVE_COMPARATOR; Interventions: Device: Percutaneous Transluminal Angioplasty (PTA) | Arm Label: Drug Eluting Balloon Angioplasty (DEB); Type: EXPERIMENTAL; Interventions: Device: Percutaneous Transluminal Angioplasty (PTA) | Intervention Type: DEVICE; Name: Percutaneous Transluminal Angioplasty (PTA); Assigned to Arm(s): Drug Eluting Balloon Angioplasty (DEB) | Intervention Type: DEVICE; Name: Percutaneous Transluminal Angioplasty (PTA); Assigned to Arm(s): Conventional Balloon Angioplasty (COBA)
C: Arm Label: Aggrenox; Type: EXPERIMENTAL; Interventions: Drug: Aggrenox | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Aggrenox; Assigned to Arm(s): Aggrenox | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Intervention Type: DEVICE; Name: Stent or stent-graft deployment; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Drug Eluting Versus Conventional Balloon Angioplasty for the Treatment of Failing Dialysis Access. A Prospective Randomized Single-Center Trial.
Brief Summary: The aim of the study is to compare the feasibility and the effectiveness, by means of immediate and long-term results, of drug eluting balloon (DEB) versus conventional balloon angioplasty for the treatment of failing dialysis access.


Options:
A: Arm Label: Balloon thrombectomy; Type: EXPERIMENTAL; Interventions: Device: Balloon thrombectomy | Arm Label: Thromboaspiration system; Type: EXPERIMENTAL; Interventions: Device: Thromboaspiration system | Intervention Type: DEVICE; Name: Balloon thrombectomy; Assigned to Arm(s): Balloon thrombectomy | Intervention Type: DEVICE; Name: Thromboaspiration system; Assigned to Arm(s): Thromboaspiration system
B: Intervention Type: PROCEDURE; Name: angioplasty; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: stent placement; Assigned to Arm(s): N/A
C: Arm Label: VIABAHN Treatment Group; Type: EXPERIMENTAL; Interventions: Device: GORE VIABAHN Endoprosthesis with PROPATEN Bioactive Surface | Arm Label: PTA Treatment Group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Percutaneous Transluminal Angioplasty | Intervention Type: DEVICE; Name: GORE VIABAHN Endoprosthesis with PROPATEN Bioactive Surface; Assigned to Arm(s): VIABAHN Treatment Group | Intervention Type: PROCEDURE; Name: Percutaneous Transluminal Angioplasty; Assigned to Arm(s): PTA Treatment Group
D: Arm Label: Conventional Balloon Angioplasty (COBA); Type: ACTIVE_COMPARATOR; Interventions: Device: Percutaneous Transluminal Angioplasty (PTA) | Arm Label: Drug Eluting Balloon Angioplasty (DEB); Type: EXPERIMENTAL; Interventions: Device: Percutaneous Transluminal Angioplasty (PTA) | Intervention Type: DEVICE; Name: Percutaneous Transluminal Angioplasty (PTA); Assigned to Arm(s): Drug Eluting Balloon Angioplasty (DEB) | Intervention Type: DEVICE; Name: Percutaneous Transluminal Angioplasty (PTA); Assigned to Arm(s): Conventional Balloon Angioplasty (COBA)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The ELOPE Study: Prospective Evaluation of Long-term Outcomes After Pulmonary Embolism
Brief Summary: The purpose of this study is to evaluate the long-term impact of Pulmonary Embolism (PE) on heart and lung function, quality of life, ability to work, symptoms of breathlessness and functional status of patients one year after their initial diagnosis and treatment for PE


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Device: ALN optional filter | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: ALN optional filter; Assigned to Arm(s): 1
B: N/A
C: Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: 0.9% Saline + Enoxaparin | Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Tenecteplase + Enoxaparin | Intervention Type: DRUG; Name: Tenecteplase + Enoxaparin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: 0.9% Saline + Enoxaparin; Assigned to Arm(s): 2
D: Arm Label: Ultrasound accelerated thrombolysis; Type: EXPERIMENTAL; Interventions: Device: EkoSonic Endovascular System | Arm Label: Intravenous unfractionated heparin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Unfractionated heparin | Intervention Type: DEVICE; Name: EkoSonic Endovascular System; Assigned to Arm(s): Ultrasound accelerated thrombolysis | Intervention Type: DRUG; Name: Unfractionated heparin; Assigned to Arm(s): Intravenous unfractionated heparin

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot Study Of A Randomized Trial Comparing Two Different Time Frames For Copper T380A Intrauterine Contraception Insertion; Immediately Postpartum Compared To 4-6 Weeks Postpartum In Lilongwe, Malawi
Brief Summary: The purpose of this non-blinded randomized clinical trial is to pilot the design of a randomized clinical trial to be conducted in Malawi to investigate immediate postpartum insertion of the Copper T380 intrauterine contraceptive device (CuT380A-IUCD) compared to placement at the 6-week postpartum visit.

The investigators hypothesize that it will be feasible to enroll 140 women into this study, and that women will find the 10 minute to 48 hour time frame for IUCD placement acceptable.


Options:
A: Arm Label: PostPlacental IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Copper T intrauterine device | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Copper T intrauterine device; Assigned to Arm(s): PostPlacental IUD insertion
B: Arm Label: Immediate postpartum IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Copper T380A Intrauterine Device | Arm Label: 6 week postpartum IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Copper T380A Intrauterine Device | Intervention Type: DEVICE; Name: Copper T380A Intrauterine Device; Assigned to Arm(s): 6 week postpartum IUD insertion, Immediate postpartum IUD insertion
C: Arm Label: postplacental insertion after cesarean; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel-releasing intrauterine system (LNG-IUS) | Arm Label: delayed insertion group; Type: ACTIVE_COMPARATOR; Interventions: Device: Levonorgestrel-releasing intrauterine system (LNG-IUS) | Intervention Type: DEVICE; Name: Levonorgestrel-releasing intrauterine system (LNG-IUS); Assigned to Arm(s): postplacental insertion after cesarean | Intervention Type: DEVICE; Name: Levonorgestrel-releasing intrauterine system (LNG-IUS); Assigned to Arm(s): delayed insertion group
D: Arm Label: Postplacental IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel-releasing IUD (Mirena) | Arm Label: Delayed IUD insertion; Type: ACTIVE_COMPARATOR; Interventions: Device: Levonorgestrel-releasing IUD (Mirena) | Intervention Type: DEVICE; Name: Levonorgestrel-releasing IUD (Mirena); Assigned to Arm(s): Delayed IUD insertion, Postplacental IUD insertion

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot Study Of A Randomized Trial Comparing Two Different Time Frames For Copper T380A Intrauterine Contraception Insertion; Immediately Postpartum Compared To 4-6 Weeks Postpartum In Lilongwe, Malawi
Brief Summary: The purpose of this non-blinded randomized clinical trial is to pilot the design of a randomized clinical trial to be conducted in Malawi to investigate immediate postpartum insertion of the Copper T380 intrauterine contraceptive device (CuT380A-IUCD) compared to placement at the 6-week postpartum visit.

The investigators hypothesize that it will be feasible to enroll 140 women into this study, and that women will find the 10 minute to 48 hour time frame for IUCD placement acceptable.


Options:
A: Arm Label: Immediate Postplacental; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer) | Arm Label: Early Postpartum; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer) | Arm Label: Interval; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer) | Intervention Type: DEVICE; Name: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer); Assigned to Arm(s): Early Postpartum, Immediate Postplacental, Interval
B: Arm Label: Immediate postpartum IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Copper T380A Intrauterine Device | Arm Label: 6 week postpartum IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Copper T380A Intrauterine Device | Intervention Type: DEVICE; Name: Copper T380A Intrauterine Device; Assigned to Arm(s): 6 week postpartum IUD insertion, Immediate postpartum IUD insertion
C: Arm Label: Postplacental IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel-releasing IUD (Mirena) | Arm Label: Delayed IUD insertion; Type: ACTIVE_COMPARATOR; Interventions: Device: Levonorgestrel-releasing IUD (Mirena) | Intervention Type: DEVICE; Name: Levonorgestrel-releasing IUD (Mirena); Assigned to Arm(s): Delayed IUD insertion, Postplacental IUD insertion
D: Arm Label: 6 weeks interval insertion; Type: OTHER; Interventions: Other: 6 weeks interval insertion | Arm Label: Immediate insertion; Type: EXPERIMENTAL; Interventions: Other: Immediate insertion | Intervention Type: OTHER; Name: Immediate insertion; Assigned to Arm(s): Immediate insertion | Intervention Type: OTHER; Name: 6 weeks interval insertion; Assigned to Arm(s): 6 weeks interval insertion

Answer: B